Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.24.4
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Apr. 30, 2023 $ 9,296 $ 84,799,263 $ (65,950,618) $ 18,857,941
Balance, shares at Apr. 30, 2023 9,295,837      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 184,531 184,531
Net loss (2,894,683) (2,894,683)
Balance at Jul. 31, 2023 $ 9,296 84,991,196 (68,845,301) 16,155,191
Balance, shares at Jul. 31, 2023 9,295,837      
Balance at Apr. 30, 2023 $ 9,296 84,799,263 (65,950,618) 18,857,941
Balance, shares at Apr. 30, 2023 9,295,837      
Net loss       (3,153,113)
Balance at Oct. 31, 2023 $ 9,332 85,379,593 (69,103,731) 16,285,194
Balance, shares at Oct. 31, 2023 9,332,277      
Balance at Jul. 31, 2023 $ 9,296 84,991,196 (68,845,301) 16,155,191
Balance, shares at Jul. 31, 2023 9,295,837      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 184,531 184,531
Net loss (258,430) (258,430)
Issuance of common stock for services $ 13 52,487 52,500
Issuance of common stock for services, shares 13,147      
Issuance of common stock for prepaid services $ 25 143,975 144,000
Issuance of common stock for prepaid services, shares 25,000      
Cancellation of shares $ (2) 2
Cancellation of shares, shares (1,707)      
Balance at Oct. 31, 2023 $ 9,332 85,379,593 (69,103,731) 16,285,194
Balance, shares at Oct. 31, 2023 9,332,277      
Balance at Apr. 30, 2024 $ 10,732 90,297,824 (72,848,101) 17,460,455
Balance, shares at Apr. 30, 2024 10,732,277      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 9,375 9,375
Net loss (4,325,305) (4,325,305)
Balance at Jul. 31, 2024 $ 10,732 90,314,601 (77,173,406) 13,151,927
Balance, shares at Jul. 31, 2024 10,732,277      
Balance at Apr. 30, 2024 $ 10,732 90,297,824 (72,848,101) 17,460,455
Balance, shares at Apr. 30, 2024 10,732,277      
Net loss       (6,427,832)
Balance at Oct. 31, 2024 $ 10,785 90,509,150 (79,275,933) 11,244,002
Balance, shares at Oct. 31, 2024 10,785,416      
Balance at Jul. 31, 2024 $ 10,732 90,314,601 (77,173,406) 13,151,927
Balance, shares at Jul. 31, 2024 10,732,277      
Accretion of stock based compensation in connection with stock option grants   7,402 7,402
Net loss (2,102,527) (2,102,527)
Issuance of common stock for exercise of stock warrants $ 15 67,185 67,200
Issuance of common stock for exercise of stock warrants, shares 15,000      
Issuance of common stock for services including accrued and prepaid services $ 30 119,970 120,000
Issuance of common stock for services including accrued and prepaid services, shares 30,212      
Issuance of common stock for vested restricted stock unit $ 8 (8)
Issuance of common stock for vested restricted stock unit, shares 7,927      
Balance at Oct. 31, 2024 $ 10,785 $ 90,509,150 $ (79,275,933) $ 11,244,002
Balance, shares at Oct. 31, 2024 10,785,416